Bisphenol A disrupts granulosa cell function.
Because of its widespread use and potential adverse biological effects, bisphenol A (BPA) represents one of the most studied endocrine-disrupting compounds. Within the reproductive system, ovarian granulosa cells have been documented as a target of BPA action, but no consensus has been reached about functional modifications induced by BPA. On these bases, we studied the potential disrupting effects of BPA on the main granulosa cell functional activities, also taking into account a potential interference with the ovarian angiogenic process. Ovarian granulosa cells were isolated from porcine follicles and cultured in the presence or absence of BPA at different concentrations for 48h. Cell proliferation was studied by measuring adenosine triphosphate content. Progesterone (P4) and estradiol 17beta (E2) production was determined by radioimmunoassay. Vascular endothelial growth factor (VEGF) output was quantified by an enzyme-linked immunosorbent assay. Redox status was monitored by measuring superoxide anion and hydrogen peroxide, and by determining the activities of the scavenging enzymes superoxide dismutase, catalase, and peroxidase by colorimetric methods. Granulosa cell proliferation as well as redox status resulted unaffected by BPA. Concentrations of E2 were stimulated by the lower BPA concentration, whereas they were inhibited by the larger doses tested. P4 output was decreased by all BPA concentrations. To the contrary, VEGF production was stimulated. Data indicate that BPA can interfere with reproductive activity by affecting granulosa cell steroidogenesis in vitro; furthermore, BPA can exert a promoting effect on the ovarian angiogenic process by increasing VEGF output in pigs. A disruption of this finely tuned process seems particularly relevant because of the risk of uncontrolled neovascularization.
Grasselli
F
F
Dipartimento di Produzioni Animali, Biotecnologie Veterinarie, Qualità e Sicurezza degli Alimenti, Italy.
Baratta
L
L
Baioni
L
L
Bussolati
S
S
Ramoni
R
R
Grolli
S
S
Basini
G
G
D000818:Animals; D001559:Benzhydryl Compounds; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D052244:Endocrine Disruptors / Q000494:pharmacology*; D004958:Estradiol / Q000096:biosynthesis; D005260:Female; D006107:Granulosa Cells / Q000187:drug effects* / Q000502:physiology*; D006861:Hydrogen Peroxide / Q000032:analysis; D018919:Neovascularization, Physiologic / Q000187:drug effects; D010053:Ovary / Q000098:blood supply; D010084:Oxidation-Reduction; D010636:Phenols / Q000008:administration & dosage / Q000494:pharmacology*; D011374:Progesterone / Q000096:biosynthesis; D013481:Superoxides / Q000032:analysis; D013552:Swine; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis; D000098826:Bisphenol A Compounds
D001559:Benzhydryl Compounds; D052244:Endocrine Disruptors; D004958:Estradiol; D006861:Hydrogen Peroxide; D010636:Phenols; D011374:Progesterone; D013481:Superoxides; D042461:Vascular Endothelial Growth Factor A; C006780:bisphenol A; D000098826:Bisphenol A Compounds